NCT01266564 An Observational Study of Avastin (Bevacizumab) in Patients With Colorectal Cancer Status COMPLETED Phase N/A
NCT01263171 Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT01262417 Resorbable Barrier for the Prevention of Abdominal and Peri-hepatic Adhesion Formation Status COMPLETED Phase PHASE2
NCT01260415 A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases Status COMPLETED Phase PHASE2
NCT01260168 Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies Status COMPLETED Phase N/A
NCT01254591 Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer Status UNKNOWN Phase NA
NCT01251666 Comparison of Hemoccult, Magstream and OC-Sensor Faecal Occult Blood Tests in Colorectal Cancer Screening Status COMPLETED Phase PHASE3
NCT01251536 Cetuximab Standard or Dose Escalation in First Line Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01243372 Biomarkers in Predicting Response to Cetuximab in Patients With Advanced Colorectal Cancer Status COMPLETED Phase N/A
NCT01239082 Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Status ACTIVE_NOT_RECRUITING Phase NA
NCT01238094 Trial of XELIRI/FOLFIRI + Simvastatin Followed by Simvastatin Maintenance in Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT01229813 Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer. Status COMPLETED Phase PHASE3
NCT01227707 A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. Status COMPLETED Phase PHASE2
NCT01226719 FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only Status COMPLETED Phase PHASE2
NCT01215539 Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patients Status COMPLETED Phase PHASE2
NCT01214681 Chemoprevention of Colorectal Cancer: the Role of Non-digestible Carbohydrates Status UNKNOWN Phase NA
NCT01214512 Performance Evaluation of the Micromedic CD24 in Vitro Diagnostic Assay Status COMPLETED Phase N/A